NewAmsterdam Pharma (NAMS) Operating Margin (2023 - 2025)
Historic Operating Margin for NewAmsterdam Pharma (NAMS) over the last 3 years, with Q3 2025 value amounting to 15845.69%.
- NewAmsterdam Pharma's Operating Margin fell 157598000.0% to 15845.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 575.81%, marking a year-over-year decrease of 276900.0%. This contributed to the annual value of 386.91% for FY2024, which is 9116500.0% up from last year.
- Latest data reveals that NewAmsterdam Pharma reported Operating Margin of 15845.69% as of Q3 2025, which was down 157598000.0% from 186.13% recorded in Q2 2025.
- NewAmsterdam Pharma's Operating Margin's 5-year high stood at 85.89% during Q3 2024, with a 5-year trough of 15845.69% in Q3 2025.
- In the last 3 years, NewAmsterdam Pharma's Operating Margin had a median value of 2306.93% in 2024 and averaged 3274.48%.
- In the last 5 years, NewAmsterdam Pharma's Operating Margin skyrocketed by 60219300bps in 2024 and then plummeted by -157598000bps in 2025.
- Over the past 3 years, NewAmsterdam Pharma's Operating Margin (Quarter) stood at 6360.4% in 2023, then soared by 95bps to 338.47% in 2024, then crashed by -4582bps to 15845.69% in 2025.
- Its last three reported values are 15845.69% in Q3 2025, 186.13% for Q2 2025, and 2314.47% during Q1 2025.